Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, announced a new release of Genedata Screener®, its enterprise platform for automated assay data analytics and consolidated assay information management across an enterprise. The new version features as a new module, Assay Performance Monitoring, the first commercially available...
Eurofins Discovery, part of the Eurofins network of laboratories and an industry-leading provider of products and services for drug discovery research, announces the launch of DiscoveryAI SAFIRE (Suite of ADMET Predictions For In Silico Refinement and Evaluation). SAFIRE is an advanced platform that leverages proprietary datasets, artificial intelligence (AI), and machine learning (ML), offering...
New Chat-based AI Interface Allows Life Sciences Executives to Unlock the Collective Power of All Their Brand Research
Trinity Life Sciences, a leader in global life sciences commercialization solutions, launched Brand Insights AI to develop, share and refine insights across the full breadth of biopharmaceutical brand research. Designed by experts...
BullFrog AI Holdings, Inc., a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, announced the appointment of Dr. Thomas W. Chittenden, PhD, DPhil, PStat, as its new Chief Scientific Officer. With a distinguished career at the intersection...
New Clinical AI care suites for Cardiology, Pulmonology, and Neurology; First-in-Class multi-modal predictive and Gen AI platform for research and clinical model development.
ConcertAI's TeraRecon, the #1 KLAS-ranked advanced visualization and AI Clinical SaaS solution, has announced that European healthcare providers now have access to its cardiology, pulmonology, and neurology...
Curia, a leading contract research, development and manufacturing organization, announced it has appointed Steve Lavezoli as vice president of biologics effective Feb. 26. Lavezoli will lead Curia’s biologics division, overseeing its discovery, development and manufacturing services.
“This is an exciting time for our biologics team, and we are pleased to...
Opentrons Labworks, Inc., a leader in lab automation and makers of accessible lab robotics, announced the appointment of Gregory Cole, PhD as Chief Innovation Officer. With over a decade of medical robotics, IP strategy, and product commercialization expertise, Dr. Cole will be responsible for establishing commercial and academic partnerships...
Evaxion Biotech A/S, a clinical research-focused biotechnology company specializing in the development of vaccines powered by AI-Immunology™, announces the success of the initial phases of its collaboration with MSD in the field of vaccines (registered trademark of Merck & Co, Inc, Rahway, NJ, United States). The vaccine development project...
Absci Corporation, a data-first generative AI drug creation company, announced the initiation of IND-enabling studies for ABS-101, a potential best-in-class anti-TL1A antibody designed using Absci’s de novo generative AI foundation model. Given a target structure, Absci uses this model to designate a specific epitope of interest, allowing for the engineering...
ADMA Biologics, Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, announced the successful initial use of its Artificial Intelligence (“AI”) program, named ADMAlytics. ADMAlytics combines AI and machine learning to improve and predict outcomes for production and operational processes. Recently, ADMA successfully produced...
